Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Financial Statements
- Click here to download Vertex Pharmaceuticals, Inc.'s Income Statement
- Click here to download Vertex Pharmaceuticals, Inc.'s Balance Sheet
- Click here to download Vertex Pharmaceuticals, Inc.'s Statement of Cash Flows
Key Info
- Industry: Pharmaceutical Preparation Manufacturing
- Sector: Manufacturing
- CEO Name: Reshma Kewalramani
Key Statistics
- Stock Price: $418.01
- Dividend Yield: 0%
- Market Capitalization: $107,975,250,166
- Shares Outstanding: 258,307,816
- Number of Employees: 4,800
- Trailing 12-Month EPS: $13.89
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2024-05-01
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $418.01
- 52-week high: $448.4
- 52-week low: $313.47
- 200-day moving average: $391.57
- 50-day moving average: $418.71
Performance
- 1-Month Price Return: -2.1%
- 3-Month Price Return: 2.7%
- 6-Month Price Return: 20.2%
- 1-Year Price Return: 33.9%
- 2-Year Price Return: 63.0%
- 5-Year Price Return: 127.2%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast